Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - ACCOUNTS PAYABLE
Accounts Payable SMMT - Summit Therapeutics Inc.
2.67 M
LAST VALUE
-21.91%
2 YEAR CAGR
-14.39%
5 YEAR CAGR
16.57%
10 YEAR CAGR